|
Fibrinolysis
Citations 61-70 of 146 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Angiotensin-Converting Enzyme Inhibition Alters the Fibrinolytic Response to Cardiopulmonary Bypass
- Mias Pretorius, Laine J. Murphey, Julie A. McFarlane, Douglas E. Vaughan, and Nancy J. Brown
Circulation 2003;108:3079-3083; published online before print as doi:10.1161/01.CIR.0000105765.54573.60
[Abstract]
[Full text]
- Correspondence
The Obsession With Primary Angioplasty
- Giovanni Melandri
Circulation 2003;108:e162, doi:10.1161/01.CIR.0000102947.33318.E8
[Full text]
- Focused Perspectives
Selecting the Best Reperfusion Strategy in ST-Elevation Myocardial Infarction: It’s All a Matter of Time
- Robert P. Giugliano and Eugene Braunwald
Circulation 2003;108:2828-2830, doi:10.1161/01.CIR.0000106684.71725.98
[Full text]
- Clinical Investigations and Reports
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial
- Philippe Gabriel Steg, Eric Bonnefoy, Sylvie Chabaud, Frédéric Lapostolle, Pierre-Yves Dubien, Pascal Cristofini, Alain Leizorovicz, Paul Touboul for the Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators
Circulation 2003;108:2851-2856; published online before print as doi:10.1161/01.CIR.0000103122.10021.F2
[Abstract]
[Full text]
- Articles
Angiotensin-Converting Enzyme Inhibition Alters the Fibrinolytic Response to Cardiopulmonary Bypass
- Mias Pretorius, Laine J. Murphey, Julie A. McFarlane, Douglas E. Vaughan, and Nancy J. Brown
Circulation published December 1, 2003, doi:10.1161/01.CIR.0000105765.54573.60
[Abstract]
- Clinical Investigations and Reports
Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction: Cost Analysis of the Canadian STAT Study
- Michel R. Le May, Richard F. Davies, Marino Labinaz, Heather Sherrard, Jean-François Marquis, Louise A. Laramée, Edward R. O’Brien, William L. Williams, Rob S. Beanlands, Graham Nichol, and Lyall A. Higginson
Circulation 2003;108:2624-2630; published online before print as doi:10.1161/01.CIR.0000097120.26062.FE
[Abstract]
[Full text]
- Articles
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty. Data From the CAPTIM Randomized Clinical Trial
- Philippe Gabriel Steg, Eric Bonnefoy, Sylvie Chabaud, Frédéric Lapostolle, Pierre-Yves Dubien, Pascal Cristofini, Alain Leizorovicz, Paul Touboul for the Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators
Circulation published November 17, 2003, doi:10.1161/01.CIR.0000103122.10021.F2
[Abstract]
- Clinical Investigations and Reports
Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction. Cost Analysis of the Canadian STAT Study
- Michel R. Le May, Richard F. Davies, Marino Labinaz, Heather Sherrard, Jean-François Marquis, Louise A. Laramée, Edward R. O’Brien, William L. Williams, Rob S. Beanlands, Graham Nichol, and Lyall A. Higginson
Circulation published November 3, 2003, doi:10.1161/01.CIR.0000097120.26062.FE
[Abstract]
- Articles
Current Status and Future Prospects for Acute Myocardial Infarction Therapy
- Eric J. Topol
Circulation 2003;108:III-6-13III-, doi:10.1161/01.CIR.0000086950.37612.7b
[Abstract]
[Full text]
- Clinical Investigations and Reports
Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial
- Kenneth W. Mahaffey, Christopher B. Granger, Jose C. Nicolau, Witold Ruzyllo, W. Douglas Weaver, Pierre Theroux, Judith S. Hochman, Thomas G. Filloon, Christopher F. Mojcik, Thomas G. Todaro, and Paul W. Armstrong
Circulation 2003;108:1176-1183; published online before print as doi:10.1161/01.CIR.0000087404.53661.F8
[Abstract]
[Full text]
|
|
